More from Curaleaf

Curaleaf Laboratories Enters Strategic Partnership with ANTG to Manufacture and Distribute Medicinal Cannabis Products in the UK

London, UK – 12th November, 2025 – Curaleaf Laboratories, one of the UK’s leading providers of medicinal cannabis products, is pleased to announce a landmark partnership with Australian Natural Therapeutics Group (ANTG), one of Australia’s most respected producers of pharmaceutical-grade medicinal cannabis. Under this agreement, Curaleaf Laboratories will manufacture and distribute ANTG’s range of products […]

Curaleaf Laboratories Partners with the Medical Cannabis Clinicians Society

Championing Clinician Education At Curaleaf Laboratories, we believe that education is the cornerstone of progress in the medical cannabis space. That’s why we’ve proudly partnered with the Medical Cannabis Clinicians Society (MCCS) to further our shared mission: empowering clinicians with credible, practical education on cannabis-based medicines. Clinician education is such a vital part of our […]

Curaleaf Laboratories Launches First Certified Liquid Medical Cannabis Inhaler for UK Patients

The Curaleaf Que Medical Inhalation Device offers precise and consistent administration of cannabis-based medicines 1st September 2025 – Curaleaf Laboratories, part of Curaleaf International, today announced the UK launch of the Curaleaf Que Medical Inhalation Device (QMID), the first CE-certified liquid inhaler for cannabis-based medicines. Available on prescription, the device offers patients a precise, discreet, […]

Curaleaf Laboratories partners with ECS Botanics for exclusive distribution of dried flower range of medical cannabis in the UK

Rokshaw can today announce an exclusive distribution partnership agreement has been reached with ECS Botanics, a leading pharmaceutical manufacturer of medical cannabis based in Australia, for their supply of their EU-GMP range of products. This partnership grants exclusive distribution of three strains of dried EU-GMP medical cannabis flowers in the UK market, widening the collective […]

Launch of Four20 Pharma Medical Cannabis Range

Rokshaw can today announce the exclusive UK manufacture and distribution of medical cannabis products, under the Four20 Pharma brand. In line with market growth and patient demand, Rokshaw have bolstered its extensive range of medical cannabis, supplying Four20 Pharma products now available for private prescription in the UK. Originating from Germany, Four20 Pharma have a […]

Extending Our Range of UK Manufactured Medical Cannabis Flower

Rokshaw Laboratories can today announce the launch of our second medical cannabis flower product, manufactured in our MHRA approved manufacturing facility in Sunderland. After responding to clinical and patient feedback, Rokshaw can now manufacture a new strain of medical cannabis flower giving another option that can be considered for prescription by a specialist prescriber. In […]

The First UK Manufacturer of Medical Cannabis Flower

Rokshaw Laboratories can today announce the launch of the first UK range of medical cannabis flower, manufactured in our MHRA approved manufacturing facility in Sunderland. Ensuring the highest level of product quality, Rokshaw is now able to manufacture a full range of medical cannabis flower, in addition to our current full spectrum oil range, to […]